Details of the Drug
General Information of Drug (ID: DMPX71O)
Drug Name |
PT-106
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Thiourea, N-(2-phenylethyl)-N'-pyrazinyl-; 149485-34-7; PETT Analog 49; PT-106; PETT Pyrazin deriv.; AC1MHDL0; BDBM1882; CHEMBL320902; SCHEMBL7082827; DTXSID50164287; 1-phenethyl-3-pyrazin-2-ylthiourea; ZINC13744909; 1-Phenethyl-3-pyrazin-2-yl-thiourea; AKOS003702467; N-(2-Phenethyl)-N -(2-pyrazinyl)thiourea
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 258.339 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 1.7 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References